Exhibit A

Joint Filing Agreement

The undersigned hereby agree that the statement on Schedule 13D with respect to the Common Stock of Instil Bio, Inc., dated as of April 5, 2021, is, and any amendments thereto (including amendments on Schedule 13G) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.

CURATIVE VENTURES V LLC
By:	CV-Immetacyte Manager LP, its manager
By:	CV-Immetacyte Ultimate Manager LLC, its general partner
By:	/s/ Bronson Crouch
	Name: Bronson Crouch
	Title: Manager
CV-IMMETACYTE MANAGER LP
By:	CV-Immetacyte Ultimate Manager LLC, its general partner
By:	/s/ Bronson Crouch
	Name: Bronson Crouch
	Title: Manager
CV-IMMETACYTE ULTIMATE MANAGER LLC
By:	/s/ Bronson Crouch
	Name: Bronson Crouch
	Title: Manager
SB2A LP
By:	SB2A Management LLC, its general partner
By:	/s/ Bronson Crouch
	Name: Bronson Crouch
	Title: Manager

SB2A Management LLC
By:	/s/ Bronson Crouch
	Name: Bronson Crouch
	Title: Manager
Bronson Crouch
/s/ Bronson Crouch